Real-World Study Evaluating Safety and Effectiveness of Axitinib in Korean Patients with Renal Cell Carcinoma after Failure of One Prior Systemic Therapy

PURPOSE: This post-marketing surveillance (PMS) study was conducted to monitor the usage of axitinib (Inlyta) in clinical practice of Korean patients with advanced renal cell carcinoma (RCC) with disease progression during or after a prior systemic therapy in real world. MATERIALS AND METHODS: In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Sang Joon, Lee, Jae Lyun, Kwon, Tae Gyun, Shim, Byoung Young, Chung, Ho Seok, Kim, Sang-Hee, Park, Se Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101802/
https://www.ncbi.nlm.nih.gov/pubmed/36470258
http://dx.doi.org/10.4143/crt.2022.883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101802/
https://www.ncbi.nlm.nih.gov/pubmed/36470258
http://dx.doi.org/10.4143/crt.2022.883

Ejemplares similares